Gaush Meditech Ltd (FRA:F7Y)

Market Cap	105.09M
Revenue (ttm)	189.02M
Net Income (ttm)	12.23M
Shares Out	n/a
EPS (ttm)	0.08
PE Ratio	8.60
Forward PE	n/a
Dividend	0.03 (4.57%)
Ex-Dividend Date	Jun 23, 2025

Volume	1,072
Average Volume	697
Open	0.7250
Previous Close	0.7250
Day's Range	0.7250 - 0.7250
52-Week Range	0.5700 - 1.6300
Beta	n/a
RSI	52.35
Earnings Date	Aug 22, 2025

About Gaush Meditech

Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, re...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 1998
• Employees: 884
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: F7Y

Financial Performance

In 2024, Gaush Meditech's revenue was 1.43 billion, an increase of 1.58% compared to the previous year's 1.41 billion. Earnings were 92.39 million, a decrease of -46.75%.

Financial numbers in CNY